World needs 22 billion more mRNA vaccine doses to ward off omicron threat, report warns

3 yıl önce

The fast-spreading omicron variant has heightened the need for billions of additional vaccine doses to protect vulnerable populations and tamp down new variants around the world, according to a new report prepared by a team of public health advocates and scientists.

Get the full experience.Choose your plan

“The scientific evidence is clear: only by universally deploying the vaccines currently most effective against infection — which for now appear to be mRNA vaccines — will we be able to blunt the virus’s evolution and begin to bring the pandemic under control globally,” the authors write in the report, which was first shared with The Washington Post.

The authors — who include advocates at PrEP4All and Partners In Health and scientists at Harvard Medical School, Columbia University, New York University and the University of Saskatchewan — conclude that about 22 billion doses of high-quality mRNA vaccines are now needed, given omicron’s ability to evade some of the immune protection conferred by prior vaccination shots. That projection would require producing an additional 15 billion doses of mRNA vaccines this year.

“With the pandemic, the global is the local. And the local is the global,” said James Krellenstein of Prep4All, pointing to omicron’s recent emergence in Southern Africa as the latest illustration of how virus variants jump borders. “What happens in Cape Town influences what happens in Brooklyn three weeks later. And what happened in Wuhan influenced what happened in Brooklyn six weeks later.”

President Biden has vowed that the United States will be an “arsenal of vaccines” for the world, pledging to donate more than 1 billion doses to other nations, a total that far outpaces other countries. The Biden administration also has moved to invest billions of dollars in expanding vaccine manufacturing capacity to support global needs.

But the report’s authors said the White House had disregarded a year of warnings to more quickly ramp up mRNA vaccine production. Only 7 billion vaccine mRNA vaccine doses are expected to be produced this year, according to manufacturers’ projections.

“You are not going to protect the American people — full stop, it does not work — until you work, seriously, to bring the pandemic under control globally. And the administration has not learned that lesson,” Krellenstein said.

Vaccine manufacturers also have warned that limits on raw materials have constrained their ability to produce new doses.

A new vaccine heading to India was developed by a small team in Texas. It expects nothing in return.

Latest on coronavirus coverage